Product Information

LYBALVI 10-10 MG TABLET is a brand product labeled by Alkermes, Inc., priced at $55.1159 per EA under NDC 65757065242. Its NADAC has been published 244 times since Mar 23, 2022.

FDA first approved this application on May 28, 2021.

LYBALVI 10-10 MG TABLET

olanzapine and samidorphan L-malate
$55.1159per EA

Strength

10; 10 mg/1; mg/1

Manufacturer

Alkermes, Inc.

NDC

65757065242

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA213378

FDA Approved

5/28/2021

On Market Since

9/20/2021

Pharmacological Classes

Price Statistics

The NADAC for LYBALVI 10-10 MG TABLET has been published 244 times since Mar 23, 2022, and over the history we have for it it has risen 24.2%. The table below summarizes its recorded NADAC range and movement.

Current price$55.1159 per EA
All-time high$55.1568 (Aug 12, 2026)
All-time low$44.3874 (Mar 23, 2022)
52-week high$55.1568
52-week low$52.5102
Median price$50.9461
Average price$50.1586
Largest weekly change+5.5% (Nov 23, 2022)
Weeks tracked244
Tracking sinceMar 23, 2022

Price History

1W

+0.0%

1M

+0.0%

3M

+0.1%

6M

-0.0%

1Y

+5.0%

3Y

+14.3%

5Y

N/A

All

+24.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olanzapine and samidorphan L-malate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LYBALVI 10-10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LYBALVI 10-10 MG TABLET, manufactured by Alkermes, Inc., is $55.1159 per EA (NDC 65757065242), effective Nov 18, 2026.

How has the price of LYBALVI 10-10 MG TABLET changed over time?

Over the history we have for it, the NADAC for LYBALVI 10-10 MG TABLET has risen 24.2%. It has been tracked across 244 weekly CMS publications since Mar 23, 2022.

What are the highest and lowest recorded NADAC prices for LYBALVI 10-10 MG TABLET?

Since Mar 23, 2022, the NADAC for LYBALVI 10-10 MG TABLET has ranged from a low of $44.3874 (Mar 23, 2022) to a high of $55.1568 (Aug 12, 2026), with a median of $50.9461 per EA.

Are there cheaper alternatives to LYBALVI 10-10 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of LYBALVI 10-10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LYBALVI 10-10 MG TABLET?

LYBALVI 10-10 MG TABLET (NDC 65757065242) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.